MXPA02012524A - Sistemas y metodos para tratar unsa superficie mucosa. - Google Patents
Sistemas y metodos para tratar unsa superficie mucosa.Info
- Publication number
- MXPA02012524A MXPA02012524A MXPA02012524A MXPA02012524A MXPA02012524A MX PA02012524 A MXPA02012524 A MX PA02012524A MX PA02012524 A MXPA02012524 A MX PA02012524A MX PA02012524 A MXPA02012524 A MX PA02012524A MX PA02012524 A MXPA02012524 A MX PA02012524A
- Authority
- MX
- Mexico
- Prior art keywords
- piston
- carbon atoms
- alkyl
- mucosal surface
- accordance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21342000P | 2000-06-22 | 2000-06-22 | |
| US09/676,339 US6486168B1 (en) | 1999-01-08 | 2000-09-29 | Formulations and methods for treatment of mucosal associated conditions with an immune response modifier |
| PCT/US2001/019979 WO2001097795A2 (en) | 2000-06-22 | 2001-06-22 | Systems and methods for treating a mucosal surface |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02012524A true MXPA02012524A (es) | 2003-04-10 |
Family
ID=26908067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02012524A MXPA02012524A (es) | 2000-06-22 | 2001-06-22 | Sistemas y metodos para tratar unsa superficie mucosa. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1296644A2 (pt) |
| JP (1) | JP2004508851A (pt) |
| CN (1) | CN1273110C (pt) |
| AU (1) | AU2001270081A1 (pt) |
| BR (1) | BR0112386A (pt) |
| CA (1) | CA2410208A1 (pt) |
| CZ (1) | CZ20024175A3 (pt) |
| EE (1) | EE200200705A (pt) |
| HR (1) | HRP20021024A2 (pt) |
| HU (1) | HUP0301233A2 (pt) |
| IL (1) | IL153087A0 (pt) |
| MX (1) | MXPA02012524A (pt) |
| NO (1) | NO20026067L (pt) |
| NZ (1) | NZ523073A (pt) |
| PL (1) | PL361975A1 (pt) |
| SK (1) | SK17812002A3 (pt) |
| WO (1) | WO2001097795A2 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0211649D0 (en) | 2002-05-21 | 2002-07-03 | Novartis Ag | Organic compounds |
| US20060247190A1 (en) | 2002-10-21 | 2006-11-02 | Kathleen Beach | Compositions and methods for treating human papillomavirus mediated disease |
| WO2005041847A2 (en) * | 2003-10-22 | 2005-05-12 | University Hospitals Of Cleveland | Method and apparatus for applying medication to internal tissue |
| US9248127B2 (en) | 2005-02-04 | 2016-02-02 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939090A (en) * | 1996-12-03 | 1999-08-17 | 3M Innovative Properties Company | Gel formulations for topical drug delivery |
| CZ20012446A3 (cs) * | 1999-01-08 | 2002-01-16 | 3M Innovative Properties Company | Farmaceutický prostředek pro léčbu onemocnění sliznice |
-
2001
- 2001-06-22 EP EP01948622A patent/EP1296644A2/en not_active Withdrawn
- 2001-06-22 CA CA002410208A patent/CA2410208A1/en not_active Abandoned
- 2001-06-22 JP JP2002503272A patent/JP2004508851A/ja not_active Abandoned
- 2001-06-22 BR BR0112386-6A patent/BR0112386A/pt not_active Application Discontinuation
- 2001-06-22 AU AU2001270081A patent/AU2001270081A1/en not_active Abandoned
- 2001-06-22 CN CNB018115144A patent/CN1273110C/zh not_active Expired - Fee Related
- 2001-06-22 MX MXPA02012524A patent/MXPA02012524A/es active IP Right Grant
- 2001-06-22 EE EEP200200705A patent/EE200200705A/xx unknown
- 2001-06-22 PL PL36197501A patent/PL361975A1/xx not_active Application Discontinuation
- 2001-06-22 SK SK1781-2002A patent/SK17812002A3/sk not_active Application Discontinuation
- 2001-06-22 IL IL15308701A patent/IL153087A0/xx unknown
- 2001-06-22 CZ CZ20024175A patent/CZ20024175A3/cs unknown
- 2001-06-22 NZ NZ523073A patent/NZ523073A/xx unknown
- 2001-06-22 HU HU0301233A patent/HUP0301233A2/hu unknown
- 2001-06-22 WO PCT/US2001/019979 patent/WO2001097795A2/en active IP Right Grant
-
2002
- 2002-12-17 NO NO20026067A patent/NO20026067L/no not_active Application Discontinuation
- 2002-12-20 HR HR20021024A patent/HRP20021024A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001097795A2 (en) | 2001-12-27 |
| SK17812002A3 (sk) | 2003-05-02 |
| AU2001270081A1 (en) | 2002-01-02 |
| EP1296644A2 (en) | 2003-04-02 |
| CZ20024175A3 (cs) | 2003-06-18 |
| PL361975A1 (en) | 2004-10-18 |
| JP2004508851A (ja) | 2004-03-25 |
| EE200200705A (et) | 2004-08-16 |
| CA2410208A1 (en) | 2001-12-27 |
| NO20026067L (no) | 2003-02-17 |
| HUP0301233A2 (hu) | 2003-08-28 |
| IL153087A0 (en) | 2003-06-24 |
| NZ523073A (en) | 2005-04-29 |
| CN1273110C (zh) | 2006-09-06 |
| CN1437463A (zh) | 2003-08-20 |
| WO2001097795A3 (en) | 2002-04-04 |
| NO20026067D0 (no) | 2002-12-17 |
| BR0112386A (pt) | 2003-06-10 |
| HRP20021024A2 (en) | 2005-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6706728B2 (en) | Systems and methods for treating a mucosal surface | |
| CA2361936C (en) | Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions | |
| US6486168B1 (en) | Formulations and methods for treatment of mucosal associated conditions with an immune response modifier | |
| US10071156B2 (en) | Aqueous gel formulations containing immune response modifiers | |
| EP1495758A2 (en) | Formulations and methods for treatment of mucosal associated conditions with an immune response modifier | |
| MXPA06002408A (es) | Metodos relacionados al tratamiento de condiciones asociadas a la mucosa. | |
| AU2011285567A1 (en) | Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream | |
| JP7280870B2 (ja) | 皮膚障害の処置 | |
| MXPA02012524A (es) | Sistemas y metodos para tratar unsa superficie mucosa. | |
| KR102666078B1 (ko) | 항바이러스성 화합물을 포함하는 질내 적용 가능한 장치 | |
| ZA200300568B (en) | Systems and methods for treating a mucosal surface. | |
| AU2006252154A1 (en) | Systems and methods for treating a mucosal surface |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GB | Transfer or rights |